HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.

Abstract
Farnesylation of the activated ras oncogene product by protein farnesyltransferase (FTase) is a critical step for its oncogenic function. Because squalene synthase and FTase recruit farnesyl pyrophosphate as a common substrate, we modified squalene synthase (SS) inhibitors to develop FTase inhibitors. Among the compounds tested, a novel FTase inhibitor termed J-104,871 inhibited rat brain FTase with an IC50 of 3.9 nM in the presence of 0.6 microM farnesyl pyrophosphate (FPP), whereas it scarcely inhibited rat brain protein geranylgeranyltransferase-I or SS. The in vitro inhibition of rat brain FTase by J-104,871 depends on the FPP concentration but not on the concentration of Ras peptide. Thus, in vitro studies strongly suggest that J-series compounds have an FPP-competitive nature. J-104,871 also inhibited Ras processing in activated H-ras-transformed NIH3T3 cells with an IC50 value of 3.1 microM. We tested the effects of lovastatin and zaragozic acid A, which modify cellular FPP levels, on Ras processing of J-104,871. Lovastatin, a hepatic hydroxymenthyl coenzyme A reductase inhibitor that reduced the cellular FPP pool, increased the activity of J-104,871, whereas 3 microM zaragozic acid A, an SS inhibitor that raised the FPP level, completely abrogated the activity of J-104,871 even at 100 microM. These results suggest that J-104,871 inhibits FTase in an FPP-competitive manner in whole cells as well as in the in vitro system. Furthermore, J-104,871 suppressed tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
AuthorsM Yonemoto, T Satoh, H Arakawa, I Suzuki-Takahashi, Y Monden, T Kodera, K Tanaka, T Aoyama, Y Iwasawa, T Kamei, S Nishimura, K Tomimoto
JournalMolecular pharmacology (Mol Pharmacol) Vol. 54 Issue 1 Pg. 1-7 (Jul 1998) ISSN: 0026-895X [Print] United States
PMID9658183 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • J 104871
  • Naphthalenes
  • Oxazoles
  • Polyisoprenyl Phosphates
  • Sesquiterpenes
  • farnesyl pyrophosphate
  • Alkyl and Aryl Transferases
  • Farnesyl-Diphosphate Farnesyltransferase
  • Farnesyltranstransferase
Topics
  • 3T3 Cells (drug effects, metabolism)
  • Alkyl and Aryl Transferases (antagonists & inhibitors)
  • Animals
  • Farnesyl-Diphosphate Farnesyltransferase (antagonists & inhibitors)
  • Farnesyltranstransferase
  • Female
  • Genes, ras (drug effects, genetics, physiology)
  • Mice
  • Mice, Nude
  • Naphthalenes (chemistry, pharmacology)
  • Oxazoles (chemistry, pharmacology)
  • Polyisoprenyl Phosphates (metabolism)
  • Protein Prenylation (drug effects)
  • Rats
  • Sesquiterpenes
  • Subrenal Capsule Assay
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: